X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (99) 99
Book Review (11) 11
Book / eBook (7) 7
Patent (6) 6
Conference Proceeding (4) 4
Publication (4) 4
Magazine Article (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
immunology (37) 37
humans (29) 29
animals (28) 28
mice (23) 23
oncology (20) 20
dendritic cells (18) 18
killer cells, natural - immunology (18) 18
natural-killer-cells (18) 18
t-cells (15) 15
immunotherapy (13) 13
nk cells (13) 13
transplantation (13) 13
dendritic cells - immunology (12) 12
killer cells (12) 12
mice, inbred c57bl (12) 12
cancer (11) 11
cell biology (11) 11
natural killer cells (11) 11
expression (10) 10
life sciences (10) 10
research (10) 10
t cells (10) 10
analysis (9) 9
health aspects (9) 9
original research (9) 9
adoptive immunotherapy (8) 8
cell line, tumor (8) 8
cytotoxicity (8) 8
female (8) 8
medicine, research & experimental (8) 8
stem cells (8) 8
apoptosis (7) 7
biochemistry & molecular biology (7) 7
cytokines (7) 7
hematology (7) 7
imatinib mesylate (7) 7
leukemia (7) 7
neoplasms - immunology (7) 7
rodents (7) 7
abridged index medicus (6) 6
activation (6) 6
antigen presentation (6) 6
cytotoxicity, immunologic (6) 6
dendritic cells - metabolism (6) 6
immunity (6) 6
in-vivo (6) 6
killer cells, natural - metabolism (6) 6
acute myeloid-leukemia (5) 5
antigens (5) 5
apoptosis-inducing ligand (5) 5
cd8-positive t-lymphocytes - immunology (5) 5
cells, cultured (5) 5
cytotoxicity, immunologic - immunology (5) 5
flow cytometry (5) 5
genetic aspects (5) 5
immune system (5) 5
interleukin-15 (5) 5
lymphocytes (5) 5
mice, inbred balb c (5) 5
mice, transgenic (5) 5
mouse (5) 5
neoplasms (5) 5
regulatory t-cells (5) 5
adaptive immunity (4) 4
animal models (4) 4
benzamides (4) 4
care and treatment (4) 4
chemistry (4) 4
death (4) 4
glivec (4) 4
human necessities (4) 4
ifn-gamma (4) 4
interferon (4) 4
interleukin-15 - immunology (4) 4
interleukins (4) 4
killer cells, natural (4) 4
male (4) 4
melanoma (4) 4
nk cell (4) 4
nk-cells (4) 4
surgical procedures, operative (4) 4
tumor immunology (4) 4
tumors (4) 4
usage (4) 4
versus-host-disease (4) 4
acute lymphoblastic-leukemia (3) 3
advanced basic science (3) 3
anticancer effector function (3) 3
antigen presentation - immunology (3) 3
antigen-presenting cells - immunology (3) 3
antineoplastic agents (3) 3
autoimmunity (3) 3
b-cells (3) 3
biological response modifiers (3) 3
biology (3) 3
bone-marrow-transplantation (3) 3
cancer research (3) 3
carrier proteins - metabolism (3) 3
cell proliferation (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Immunology, ISSN 1664-3224, 2012, Volume 3, pp. 388 - 388
There is a wide range of important pharmaceuticals used in treatment of cancer. Besides their known effects on tumor cells, there is growing evidence for... 
TKi | Lenalidomide | NK cell | Glivec | bortezomib | HDACi | Imid | Thalidomide | IMiD (R) | TKI | thalidomide | lenalidomide | IMMUNOLOGY | Glivec (R) | Bortezomib | IMiD
Journal Article
Nature Medicine, ISSN 1078-8956, 09/2007, Volume 13, Issue 9, pp. 1050 - 1059
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2006, Volume 12, Issue 2, pp. 214 - 219
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 7, pp. 1935 - 1945
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2016, Volume 139, Issue 8, pp. 1799 - 1809
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2564
Journal Article
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 01/2016, Volume 8, Issue 1, pp. 39 - 57
Glioblastoma multiforme ( GBM ) is treated by surgical resection followed by radiochemotherapy. Bevacizumab is commonly deployed for anti‐angiogenic therapy of... 
macrophage polarization | anti‐angiogenic therapy | glioblastoma | tumor angiogenesis | therapy resistance | Tumor angiogenesis | Anti-angiogenic therapy | Therapy resistance | Macrophage polarization | Glioblastoma | MEDICINE, RESEARCH & EXPERIMENTAL | anti-angiogenic therapy | NEWLY-DIAGNOSED GLIOBLASTOMA | OVARIAN-CANCER | SERUM ANGIOPOIETIN-2 | ANTIANGIOGENIC THERAPY | COLORECTAL-CANCER | TIE2-EXPRESSING MONOCYTES | POTENT ANTITUMOR | TUMOR-ASSOCIATED MACROPHAGES | DISEASE PROGRESSION | Mannose-Binding Lectins - metabolism | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - pharmacology | Humans | Receptors, Vascular Endothelial Growth Factor - pharmacology | Recombinant Fusion Proteins - therapeutic use | Brain Neoplasms - pathology | Drug Resistance, Neoplasm | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Angiopoietin-2 - metabolism | Brain - metabolism | Lectins, C-Type - metabolism | Neoplasm Grading | Female | Brain Neoplasms - mortality | Macrophages - immunology | Angiopoietin-2 - blood | Disease Models, Animal | Endothelial Cells - metabolism | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Mice, Transgenic | Macrophages - cytology | Brain Neoplasms - drug therapy | Up-Regulation - drug effects | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Endothelial Cells - cytology | Glioblastoma - pathology | Brain - pathology | Mice | Angiopoietin-2 - antagonists & inhibitors | Glioblastoma - drug therapy | Glioblastoma - mortality | Analysis | Permeability | Angiogenesis inhibitors | T cells | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Endothelium | Angiogenesis | Rodents | Index Medicus | Neuroscience | s | Pharmacology & Drug Discovery | Cancer
Journal Article
by Mathew, Nimitha R and Baumgartner, Francis and Braun, Lukas and O'Sullivan, David and Thomas, Simone and Waterhouse, Miguel and Müller, Tony A and Hanke, Kathrin and Taromi, Sanaz and Apostolova, Petya and Illert, Anna L and Melchinger, Wolfgang and Duquesne, Sandra and Schmitt-Graeff, Annette and Osswald, Lena and Yan, Kai-Li and Weber, Arnim and Tugues, Sonia and Spath, Sabine and Pfeifer, Dietmar and Follo, Marie and Claus, Rainer and Lübbert, Michael and Rummelt, Christoph and Bertz, Hartmut and Wäsch, Ralph and Haag, Johanna and Schmidts, Andrea and Schultheiss, Michael and Bettinger, Dominik and Thimme, Robert and Ullrich, Evelyn and Tanriver, Yakup and Vuong, Giang Lam and Arnold, Renate and Hemmati, Philipp and Wolf, Dominik and Ditschkowski, Markus and Jilg, Cordula and Wilhelm, Konrad and Leiber, Christian and Gerull, Sabine and Halter, Jörg and Lengerke, Claudia and Pabst, Thomas and Schroeder, Thomas and Kobbe, Guido and Rösler, Wolf and Doostkam, Soroush and Meckel, Stephan and Stabla, Kathleen and Metzelder, Stephan K and Halbach, Sebastian and Brummer, Tilman and Hu, Zehan and Dengjel, Joern and Hackanson, Björn and Schmid, Christoph and Holtick, Udo and Scheid, Christof and Spyridonidis, Alexandros and Stölzel, Friedrich and Ordemann, Rainer and Müller, Lutz P and Sicre-De-Fontbrune, Flore and Ihorst, Gabriele and Kuball, Jürgen and Ehlert, Jan E and Feger, Daniel and Wagner, Eva-Maria and Cahn, Jean-Yves and Schnell, Jacqueline and Kuchenbauer, Florian and Bunjes, Donald and Chakraverty, Ronjon and Richardson, Simon and Gill, Saar and Kröger, Nicolaus and Ayuk, Francis and Vago, Luca and Ciceri, Fabio and Müller, Antonia M and Kondo, Takeshi and Teshima, Takanori and Klaeger, Susan and Kuster, Bernhard and Kim, Dennis H and Weisdorf, Daniel and Van Der Velden, Walter and Dörfel, Daniela and Bethge, Wolfgang and Hilgendorf, Inken and Hochhaus, Andreas and Andrieux, Geoffroy and Börries, Melanie and Busch, Hauke and Magenau, John and Reddy, Pavan and Labopin, Myriam and Antin, Joseph H and ...
Nature Medicine, ISSN 1078-8956, 03/2018, Volume 24, Issue 3, pp. 282 - 291
Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who... 
ALLO-SCT | MEDICINE, RESEARCH & EXPERIMENTAL | INTERNAL TANDEM DUPLICATION | CONTROLLED-TRIAL | ACUTE GVHD | BIOCHEMISTRY & MOLECULAR BIOLOGY | REGULATORY FACTOR | ACUTE MYELOID-LEUKEMIA | TUMOR ACTIVITY | CELL BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HOST-DISEASE | SEQUENCING DATA | Sorafenib - administration & dosage | Leukemia, Myeloid, Acute - pathology | Humans | Activating Transcription Factor 4 - genetics | Sorafenib - adverse effects | Interferon Regulatory Factor-7 - genetics | Graft vs Host Disease - pathology | fms-Like Tyrosine Kinase 3 - genetics | Graft vs Host Disease - genetics | Animals | Interleukin-15 - genetics | Graft vs Host Disease - drug therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Mice | Gene Expression Regulation, Neoplastic - drug effects | CD8-Positive T-Lymphocytes - immunology | Cellular Reprogramming - genetics | Tandem Repeat Sequences - genetics | Leukemia, Myeloid, Acute - genetics | Transplantation, Homologous - adverse effects | Interleukin-15 | Gene mutations | Gene expression | Health aspects | Chromatin | Animal models | Bcl-2 protein | PD-1 protein | CD8 antigen | Leukemia | Activation | Transplantation | Lymphocytes T | Synergism | Mitochondria | Cell activation | Lymphocytes | Rodents | Transcription activation | Flexible manufacturing systems | Protein-tyrosine kinase | Tyrosine | Cell survival | Myeloid leukemia | Activating transcription factor 4 | Interleukin 15 | Survival | Cells | Hemopoiesis | Interferon regulatory factor 7 | γ-Interferon | Glycolysis | Interferon | Acute myeloid leukemia | Interferon regulatory factor | Index Medicus
Journal Article